Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Murati

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Retina (Philadelphia, Pa.)|September 1, 2016
CorrespondenceJuan Yepez, Felipe Murati, J Fernando Arévalo
Case Reports in Ophthalmological Medicine|October 29, 2015
Pseudotumoral and Multiple Retinal Pigment Epithelium Proliferation in Vogt-Koyanagi-Harada DiseaseJuan B Yepez, Felipe Murati, Michele Petitto, et al.
Translational Vision Science & Technology|November 21, 2025
Application of Deep Learning for Advanced Detection and Quantification of Drusen in Nonexudative AMD From Retinal Multispectral ImagingIgor Kozak, Stephen H Sinclair, Emily Zhang, et al.
Survey of Ophthalmology|February 26, 2026
Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidenceFelipe Murati, Parichehr Ghahari, Tawanda Zvavamwe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Retina (Philadelphia, Pa.)|September 1, 2016
CorrespondenceJuan Yepez, Felipe Murati, J Fernando Arévalo
Case Reports in Ophthalmological Medicine|October 29, 2015
Pseudotumoral and Multiple Retinal Pigment Epithelium Proliferation in Vogt-Koyanagi-Harada DiseaseJuan B Yepez, Felipe Murati, Michele Petitto, et al.
Translational Vision Science & Technology|November 21, 2025
Application of Deep Learning for Advanced Detection and Quantification of Drusen in Nonexudative AMD From Retinal Multispectral ImagingIgor Kozak, Stephen H Sinclair, Emily Zhang, et al.
Survey of Ophthalmology|February 26, 2026
Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidenceFelipe Murati, Parichehr Ghahari, Tawanda Zvavamwe, et al.
Pageof 1